Blood cancer bleeding breakthrough? tranexamic acid trial shows promise
Disease control
Completed
This study tested whether a drug called tranexamic acid can lower the risk of serious bleeding or death in people with blood cancers who have very low platelet counts. Over 600 adults receiving chemotherapy or a stem cell transplant were randomly given either the drug or a placeb…
Phase: PHASE3 • Sponsor: NHS Blood and Transplant • Aim: Disease control
Last updated May 26, 2026 09:55 UTC